Topic

Ultomiris (ravulizumab)

A collection of 32 issues

Aetna (CVS Health)'s Coverage Criteria for Ultomiris (ravulizumab) in Virginia: What Counts as "Medically Necessary"?

Quick Answer: Aetna (CVS Health) requires prior authorization for Ultomiris (ravulizumab) across all FDA-approved indications in Virginia. Submit form GR-69447 with diagnosis-specific labs, REMS compliance proof, and vaccination records. If denied, Virginia's State Corporation Commission provides free external review within 120 days. First step: Verify your coverage and

Work With Your Doctor to Get Ultomiris (Ravulizumab) Approved by Blue Cross Blue Shield in Washington: Provider Partnership Guide

Answer Box: Getting Ultomiris Covered in Washington To get Ultomiris (ravulizumab) approved by Blue Cross Blue Shield in Washington, you need prior authorization with specific clinical documentation for PNH, aHUS, myasthenia gravis, or NMOSD. Your doctor must submit lab results (flow cytometry for PNH, complement studies for aHUS), proof of

How to Get Ultomiris (Ravulizumab) Covered by UnitedHealthcare in Ohio: Prior Authorization, Appeals, and Step Therapy Override Guide

Answer Box: Getting Ultomiris Approved by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Ultomiris (ravulizumab) with step therapy typically requiring eculizumab (Soliris) first. Submit PA through OptumRx (1-800-711-4555) or UnitedHealthcare provider portal. If denied, request peer-to-peer review within one business day, then file internal appeal within 180 days. Ohio

The Requirements Checklist to Get Ultomiris (ravulizumab) Covered by Aetna (CVS Health) in Michigan: Forms, Appeals, and Approval Timeline

Answer Box: Getting Ultomiris (ravulizumab) Covered by Aetna (CVS Health) in Michigan Aetna requires prior authorization for Ultomiris (ravulizumab) across all FDA-approved indications (PNH, aHUS, anti-AChR+ myasthenia gravis, AQP4+ NMOSD). Your fastest path to approval: 1) Verify active coverage and specialty pharmacy benefits, 2) Complete Aetna's precertification form

How to Get Ultomiris (Ravulizumab) Covered by Cigna in Ohio: Prior Authorization, Appeals, and Alternative Options

Quick Answer: Getting Ultomiris Covered by Cigna in Ohio Cigna requires prior authorization for Ultomiris (ravulizumab) through Express Scripts/Accredo specialty pharmacy. Your hematologist or neurologist must submit medical necessity documentation showing diagnosis confirmation (ICD-10 codes), prior therapy failures, and vaccination requirements. If denied, Ohio residents have 180 days for

How to Get Ultomiris (ravulizumab) Approved by UnitedHealthcare in North Carolina: Complete Prior Authorization Guide

Answer Box: Getting Ultomiris Approved by UnitedHealthcare in North Carolina To get Ultomiris (ravulizumab) covered by UnitedHealthcare in North Carolina, you'll need prior authorization with documented medical necessity. Most plans require step therapy (trying eculizumab/Soliris first) unless you qualify for an exception. The fastest path: 1) Verify

The Requirements Checklist to Get Ultomiris (ravulizumab) Covered by UnitedHealthcare in Illinois: Complete PA Guide

Answer Box: Getting Ultomiris Covered by UnitedHealthcare in Illinois Fastest path to approval: Submit prior authorization through UnitedHealthcare Provider Portal with complete clinical documentation showing FDA-approved indication (PNH, aHUS, gMG, or NMOSD), meningococcal vaccination records, and step therapy exception if bypassing eculizumab. In Illinois, you have strong appeal rights including

How to Get Ultomiris (ravulizumab) Covered by Cigna in Washington: Forms, Appeals, and Patient Rights

Answer Box: Quick Path to Ultomiris Coverage To get Ultomiris (ravulizumab) covered by Cigna in Washington: Your doctor submits a prior authorization using Cigna's Ultomiris PA form via CoverMyMeds portal or fax (855) 840-1678. Include diagnosis-specific documentation (anti-AChR antibodies for gMG, anti-AQP4 for NMOSD), prior therapy failures, and

How to Get Ultomiris (ravulizumab) Covered by UnitedHealthcare in New Jersey: Coding, Appeals, and Step Therapy Exceptions

Answer Box: Getting Ultomiris Covered by UnitedHealthcare in New Jersey Ultomiris (ravulizumab) requires prior authorization from UnitedHealthcare in New Jersey, with step therapy typically requiring eculizumab (Soliris) or biosimilars first. To get approval: 1) Submit PA with proper ICD-10 codes (D59.5 for PNH, D59.3 series for aHUS), HCPCS

Aetna (CVS Health) Coverage Criteria for Ultomiris (ravulizumab) in New York: What Counts as "Medically Necessary"?

Answer Box: Getting Ultomiris Covered by Aetna (CVS Health) in New York Ultomiris (ravulizumab) requires prior authorization from Aetna (CVS Health) for all FDA-approved indications (PNH, aHUS, anti-AChR+ generalized myasthenia gravis, and NMOSD). Coverage requires meeting diagnosis-specific criteria, meningococcal vaccination, and documentation of clinical necessity. Quick start: 1) Verify your